General And Administrative Expense of ProQR Therapeutics N.V. from 31 Dec 2015 to 30 Sep 2024

Taxonomy & unit
ifrs-full: EUR
Summary
ProQR Therapeutics N.V. quarterly and annual General And Administrative Expense in EUR history and change rate from 31 Dec 2015 to 30 Sep 2024.
  • ProQR Therapeutics N.V. General And Administrative Expense for the quarter ending 30 Sep 2024 was €3,283,000, a 0.96% decline year-over-year.
  • ProQR Therapeutics N.V. General And Administrative Expense for the twelve months ending 30 Sep 2024 was €14,498,000, a 0.28% increase year-over-year.
  • ProQR Therapeutics N.V. annual General And Administrative Expense for 2023 was €16,236,000, a 13% decline from 2022.
  • ProQR Therapeutics N.V. annual General And Administrative Expense for 2022 was €18,651,000, a 7.4% increase from 2021.
  • ProQR Therapeutics N.V. annual General And Administrative Expense for 2021 was €17,368,000, a 27% increase from 2020.
Source SEC data
View on sec.gov
General And Administrative Expense, Trailing 12 Months (EUR)
General And Administrative Expense, Quarterly (EUR)
General And Administrative Expense, YoY Quarterly Change (%)
General And Administrative Expense, Annual (EUR)
General And Administrative Expense, YoY Annual Change (%)

ProQR Therapeutics N.V. Quarterly General And Administrative Expense (EUR)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 €14,498,000 €3,283,000 -€32,000 -0.96% 01 Jul 2024 30 Sep 2024 6-K 07 Nov 2024 2024 Q3
Q2 2024 €14,530,000 €3,013,000 -€1,132,000 -27% 01 Apr 2024 30 Jun 2024 6-K 08 Aug 2024 2024 Q2
Q1 2024 €15,662,000 €3,452,000 -€574,000 -14% 01 Jan 2024 31 Mar 2024 6-K 09 May 2024 2024 Q1
Q4 2023 €16,236,000 €4,750,000 +€1,778,000 +60% 01 Oct 2023 31 Dec 2023 20-F 13 Mar 2024 2023 FY
Q3 2023 €14,458,000 €3,315,000 -€2,044,000 -38% 01 Jul 2023 30 Sep 2023 6-K 07 Nov 2024 2024 Q3
Q2 2023 €16,502,000 €4,145,000 -€1,267,000 -23% 01 Apr 2023 30 Jun 2023 6-K 08 Aug 2024 2024 Q2
Q1 2023 €17,769,000 €4,026,000 -€882,000 -18% 01 Jan 2023 31 Mar 2023 6-K 09 May 2024 2024 Q1
Q4 2022 €18,651,000 €2,972,000 -€2,344,000 -44% 01 Oct 2022 31 Dec 2022 20-F 13 Mar 2024 2023 FY
Q3 2022 €20,995,000 €5,359,000 +€768,000 +17% 01 Jul 2022 30 Sep 2022 6-K 07 Nov 2023 2023 Q3
Q2 2022 €20,227,000 €5,412,000 +€1,290,000 +31% 01 Apr 2022 30 Jun 2022 6-K 03 Aug 2023 2023 Q2
Q1 2022 €18,937,000 €4,908,000 +€1,569,000 +47% 01 Jan 2022 31 Mar 2022 6-K 16 May 2023 2023 Q1
Q4 2021 €17,368,000 €5,316,000 +€1,804,000 +51% 01 Oct 2021 31 Dec 2021 6-K 24 Feb 2022 2021 FY
Q3 2021 €15,564,000 €4,591,000 +€1,782,000 +63% 01 Jul 2021 30 Sep 2021 6-K 09 Nov 2022 2022 Q3
Q2 2021 €13,782,000 €4,122,000 +€676,000 +20% 01 Apr 2021 30 Jun 2021 6-K 04 Aug 2022 2022 Q2
Q1 2021 €13,106,000 €3,339,000 -€579,000 -15% 01 Jan 2021 31 Mar 2021 6-K 05 May 2022 2022 Q1
Q4 2020 €13,685,000 €3,512,000 -€405,000 -10% 01 Oct 2020 31 Dec 2020 6-K 24 Feb 2022 2021 FY
Q3 2020 €14,090,000 €2,809,000 -€94,000 -3.2% 01 Jul 2020 30 Sep 2020 6-K 04 Nov 2021 2021 Q3
Q2 2020 €14,184,000 €3,446,000 +€570,000 +20% 01 Apr 2020 30 Jun 2020 6-K 05 Aug 2021 2021 Q2
Q1 2020 €13,614,000 €3,918,000 +€727,000 +23% 01 Jan 2020 31 Mar 2020 6-K 07 May 2020 2020 Q1
Q4 2019 €12,887,000 €3,917,000 01 Oct 2019 31 Dec 2019 6-K 25 Feb 2021 2020 FY
Q3 2019 €2,903,000 +€324,000 +13% 01 Jul 2019 30 Sep 2019 6-K 16 Nov 2020 2020 Q3
Q2 2019 €2,876,000 +€227,000 +8.6% 01 Apr 2019 30 Jun 2019 6-K 06 Aug 2020 2020 Q2
Q1 2019 €3,191,000 01 Jan 2019 31 Mar 2019 6-K 07 May 2020 2020 Q1
Q3 2018 €2,579,000 01 Jul 2018 30 Sep 2018 6-K 12 Nov 2019 2019 Q3
Q2 2018 €2,649,000 -€243,000 -8.4% 01 Apr 2018 30 Jun 2018 6-K 07 Aug 2019 2019 H1
Q2 2017 €2,892,000 01 Apr 2017 30 Jun 2017 6-K 08 Aug 2018 2018 Q2

ProQR Therapeutics N.V. Annual General And Administrative Expense (EUR)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 €16,236,000 -€2,415,000 -13% 01 Jan 2023 31 Dec 2023 20-F 13 Mar 2024 2023 FY
2022 €18,651,000 +€1,283,000 +7.4% 01 Jan 2022 31 Dec 2022 20-F 13 Mar 2024 2023 FY
2021 €17,368,000 +€3,683,000 +27% 01 Jan 2021 31 Dec 2021 20-F 13 Mar 2024 2023 FY
2020 €13,685,000 +€798,000 +6.2% 01 Jan 2020 31 Dec 2020 20-F 29 Mar 2023 2022 FY
2019 €12,887,000 +€347,000 +2.8% 01 Jan 2019 31 Dec 2019 20-F 29 Apr 2022 2021 FY
2018 €12,540,000 +€1,700,000 +16% 01 Jan 2018 31 Dec 2018 20-F 24 Mar 2021 2020 FY
2017 €10,840,000 +€1,362,000 +14% 01 Jan 2017 31 Dec 2017 20-F 31 Mar 2020 2019 FY
2016 €9,478,000 +€2,641,000 +39% 01 Jan 2016 31 Dec 2016 20-F 28 Mar 2019 2018 FY
2015 €6,837,000 01 Jan 2015 31 Dec 2015 20-F 30 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.